Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma

BACKGROUND: Bone lytic lesion in Multiple myeloma are the most commonly presented symptoms which require treatment with bisphosphonates (BPs). BPs are providing supportive care, reducing the rate of skeletal morbidity but evidently not abolishing it, the criteria for stopping their administration ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Krstevska, Svetlana, Stavric, Sonja Genadieva, Cevrevska, Lidija, Georgjievski, Borce, Karanfilski, Oliver, Sotirova, Tatjana, Balkanov, Trajan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720463/
https://www.ncbi.nlm.nih.gov/pubmed/26843726
http://dx.doi.org/10.5455/medarh.2015.69.367-370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720463/
https://www.ncbi.nlm.nih.gov/pubmed/26843726
http://dx.doi.org/10.5455/medarh.2015.69.367-370

Ejemplares similares